Cargando…
T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis
Although bronchiectasis pathophysiology has been historically understood around the presence of airway neutrophilic inflammation, recent experiences are consistent with the identification of a type 2 inflammation (T2) high endotype in bronchiectasis. In order to evaluate prevalence and clinical char...
Autores principales: | Oriano, Martina, Gramegna, Andrea, Amati, Francesco, D’Adda, Alice, Gaffuri, Michele, Contoli, Marco, Bindo, Francesco, Simonetta, Edoardo, Di Francesco, Carlotta, Santambrogio, Martina, Sotgiu, Giovanni, Blasi, Francesco, Aliberti, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301446/ https://www.ncbi.nlm.nih.gov/pubmed/34356836 http://dx.doi.org/10.3390/biomedicines9070772 |
Ejemplares similares
-
The biology of pulmonary exacerbations in bronchiectasis
por: Amati, Francesco, et al.
Publicado: (2019) -
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients
por: Aliberti, Stefano, et al.
Publicado: (2022) -
Neutrophil elastase in bronchiectasis
por: Gramegna, Andrea, et al.
Publicado: (2017) -
Prevalence and incidence of bronchiectasis in Italy
por: Aliberti, Stefano, et al.
Publicado: (2020) -
Protease–Antiprotease Imbalance in Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)